These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22198512)

  • 1. Association of soluble receptor for advanced glycation end-product with increasing central aortic stiffness in hypertensive patients.
    Yoon SJ; Park S; Park C; Chang W; Cho DK; Ko YG; Choi D; Kwon HM; Jang Y; Chung N
    Coron Artery Dis; 2012 Mar; 23(2):85-90. PubMed ID: 22198512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble receptor for advanced glycation end-product levels are related to albuminuria and arterial stiffness in essential hypertension.
    Dimitriadis K; Tsioufis C; Kasiakogias A; Miliou A; Poulakis M; Kintis K; Bafakis I; Benardis E; Tousoulis D; Stefanadis C
    Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):382-8. PubMed ID: 22212601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble receptor for advanced glycation end products levels and aortic augmentation index in early rheumatoid arthritis--a prospective study.
    Tam LS; Shang Q; Li EK; Wong S; Li RJ; Lee KL; Leung YY; Ying KY; Yim CW; Kun EW; Leung MH; Li M; Li TK; Zhu TY; Chui RK; Tseung L; Yu SL; Kuan WP; Yu CM
    Semin Arthritis Rheum; 2013 Feb; 42(4):333-45. PubMed ID: 22920235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial stiffness and wave reflections in relation to plasma advanced glycation end products in a Chinese population.
    Huang QF; Sheng CS; Liu M; Li FH; Li Y; Wang JG
    Am J Hypertens; 2013 Jun; 26(6):754-61. PubMed ID: 23449605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
    Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
    Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end-products and arterial stiffness in hypertension.
    McNulty M; Mahmud A; Feely J
    Am J Hypertens; 2007 Mar; 20(3):242-7. PubMed ID: 17324733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
    Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
    Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD).
    Leonardis D; Basta G; Mallamaci F; Cutrupi S; Pizzini P; Tripepi R; Tripepi G; De Caterina R; Zoccali C
    Nutr Metab Cardiovasc Dis; 2012 Sep; 22(9):748-55. PubMed ID: 21470837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum levels of advanced glycation end products and their monocyte receptors in patients with type 2 diabetes.
    Su XD; Li SS; Tian YQ; Zhang ZY; Zhang GZ; Wang LX
    Arch Med Res; 2011 Oct; 42(7):596-601. PubMed ID: 22100610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low levels of plasma soluble receptor for advanced glycation end products are associated with severe leukoaraiosis in acute stroke patients.
    Yokota C; Minematsu K; Tomii Y; Naganuma M; Ito A; Nagasawa H; Yamaguchi T
    J Neurol Sci; 2009 Dec; 287(1-2):41-4. PubMed ID: 19801152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble receptor for advanced glycation end products and liver stiffness in postoperative biliary atresia.
    Honsawek S; Vejchapipat P; Payungporn S; Theamboonlers A; Chongsrisawat V; Poovorawan Y
    Clin Biochem; 2013 Feb; 46(3):214-8. PubMed ID: 23195134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.
    Sternberg Z; Weinstock-Guttman B; Hojnacki D; Zamboni P; Zivadinov R; Chadha K; Lieberman A; Kazim L; Drake A; Rocco P; Grazioli E; Munschauer F
    Mult Scler; 2008 Jul; 14(6):759-63. PubMed ID: 18505774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis.
    Basta G; Castagnini M; Del Turco S; Epistolato MC; Righini P; Sangiorgi GM; De Caterina R; Tanganelli P
    Eur J Clin Invest; 2009 Dec; 39(12):1065-72. PubMed ID: 19811526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension.
    Geroldi D; Falcone C; Emanuele E; D'Angelo A; Calcagnino M; Buzzi MP; Scioli GA; Fogari R
    J Hypertens; 2005 Sep; 23(9):1725-9. PubMed ID: 16093918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension.
    Pietri P; Vyssoulis G; Vlachopoulos C; Zervoudaki A; Gialernios T; Aznaouridis K; Stefanadis C
    J Hypertens; 2006 Nov; 24(11):2231-8. PubMed ID: 17053545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2009 Aug; 120(2):119-22. PubMed ID: 19053950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Diabetes Metab Res Rev; 2008 Feb; 24(2):109-14. PubMed ID: 17694504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
    Kalousová M; Jáchymová M; Mestek O; Hodková M; Kazderová M; Tesar V; Zima T
    Nephrol Dial Transplant; 2007 Jul; 22(7):2020-6. PubMed ID: 17347281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.